MedTrace Logo

PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin

NCT02273908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 331

Last updated 2021-02-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effect of pregabalin comparing with the conventional analgesic care in chronic low back pain patients with accompanying lower limb pain (neuropathic component) treated in primary care settings under routine clinical practice.

Conditions

  • Low-Back Pain

Interventions

OTHER

No intervention

The study is observational

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Koichi Fujii, MD · Director of Pain/Neuroscience Medical Affairs,Pfizer Japan Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-02-28
Completion
2015-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02273908 on ClinicalTrials.gov